Quick Answer: For 2026, Jabra Enhance is the better OTC hearing aid to buy new, and the gap has widened: Lexie’s parent company, LXE Hearing, announced in July 2026 that it is winding down all U.S. operations, with support and warranty guaranteed only through September 15, 2026. Jabra’s current flagship, the Enhance Select 700 (successor to the Select 500 that earned an “A” SoundGrade from HearAdvisor, top 5% of devices), bundles licensed-audiologist remote care, a 100-day trial, and a 3-year warranty for ~$1,695 on sale (regularly $1,995). Lexie’s flagship B2 Powered by Bose still lists around $999/pair (often discounted to ~$799) with genuinely good Bose-tuned sound, but the wind-down means we can no longer recommend it for a new purchase. Both are FDA-regulated OTC receiver-in-canal devices for adults with perceived mild-to-moderate hearing loss.
2026 update — read before buying: Lexie’s parent company, LXE Hearing (formed by the 2025 merger of Eargo and hearX/Lexie), announced it is ending all U.S. operations, with support and warranty claims guaranteed only through September 15, 2026, per HearingTracker. Until the situation clarifies, we can’t recommend buying a new Lexie device — a hearing aid without ongoing app support or warranty service is a bad bet. Existing Lexie owners should still get service through the September 2026 deadline. For a currently-supported alternative, see the Jabra Enhance Select 50R (~$1,195) below.
Lexie and Jabra are two of the most cross-shopped over-the-counter hearing aid brands, and it’s easy to see why: both make genuinely good behind-the-ear self-fitting devices for perceived mild-to-moderate loss, both sell online without a prescription, and both undercut the ~$3,000-per-pair average of a clinic fitting. Lexie historically led on price and simplicity while Jabra led on lab-grade sound and professional care — but Lexie’s 2026 wind-down news changes the calculus for anyone buying today. Here’s how they compare on the things that actually matter.
Lexie vs Jabra at a glance, by the numbers
- ~$999 vs ~$1,695 per pair — the flagship Lexie B2 Powered by Bose lists near $999 (frequently discounted toward $799), while the current Jabra Enhance Select 700 runs about $1,695 on sale (regularly $1,995). Lexie remains cheaper on paper, but see the wind-down note above before buying new.
- September 15, 2026 is the date HearingTracker reports Lexie’s parent company LXE Hearing will stop guaranteeing support and warranty service, as it winds down all U.S. operations — the single biggest factor in this comparison right now.
- “A” SoundGrade, top 5% — the Jabra Enhance Select 500 (predecessor to today’s Select 700) ranked in the top 5% of all devices tested by the independent lab HearAdvisor. Lexie’s B-series leans on self-fitting sound technology developed with Bose, historically praised for clarity in noise.
- ~$3,000 per pair is the average out-of-pocket cost of traditional prescription hearing aids, per the President’s Council of Advisors on Science and Technology (PCAST) — both Lexie ($799–$999) and Jabra ($1,195–$1,995) land well under that.
- 28.8 million U.S. adults could benefit from hearing aids, according to the NIDCD (National Institute on Deafness and Other Communication Disorders), yet fewer than one in three adults over 70 who could benefit has ever used them — OTC brands like these exist to close that gap.
- 100 days + 3 years vs 45 days + 1 year — Jabra Enhance includes a 100-day risk-free trial and a 3-year warranty with licensed-audiologist care; Lexie advertises a 45-day risk-free trial with support only guaranteed through the September 2026 wind-down deadline.
Lexie vs Jabra: head-to-head
| Factor | Lexie (Powered by Bose) | Jabra Enhance |
|---|---|---|
| Top OTC model | Lexie B2 (RIC) | Enhance Select 700 (RIC, replaced Select 500 Sept 2025) |
| Price (pair) | ~$799–$999 | ~$1,195–$1,995 |
| Style | Receiver-in-canal, behind-the-ear | Receiver-in-canal, discreet |
| Battery | Rechargeable (B2); size-312 (Lumen) | Rechargeable |
| Bluetooth streaming | Calls + audio (B2); iPhone-focused (B2 Plus) | Calls + media, iPhone & Android |
| Sound tuning | Self-fit, developed with Bose | Prescription-grade processing |
| Human support | Unlimited expert help by phone & text | Remote care from licensed audiologists |
| Lab sound rating | Bose-tuned (praised for clarity) | "A" (top 5%, HearAdvisor, Select 500 rating) |
| Trial / warranty | 45-day trial, support only to Sept 2026 ⚠️ | 100-day trial, 3-year warranty |
| 2026 availability | ⚠️ Parent LXE Hearing winding down US ops | Fully supported, current lineup |
The case for Lexie (Powered by Bose)
Lexie B2 Powered by Bose
- Self-fitting sound technology developed with Bose, tuned entirely in the Lexie app — no audiologist visit, per Lexie.
- Rechargeable case plus Bluetooth streaming for calls and media.
- Historically unlimited expert support by phone and text, plus a 45-day risk-free trial, per Lexie.
- ⚠️ Parent company LXE Hearing is winding down all U.S. operations; support and warranty guaranteed only through September 15, 2026.
Lexie’s hardware advantage is still real: Bose-derived self-fitting sound — historically a premium feature — at a price hundreds of dollars below Jabra, plus a support team you could call or text for help with fitting and adjustments. The rechargeable B2 is the flagship, the B2 Plus tunes its streaming around iPhone users, and the older Lexie Lumen (~$799, size-312 batteries) is the budget entry point. But as of July 2026, parent company LXE Hearing is ending all U.S. operations, with support and warranty guaranteed only through September 15, 2026 — a real risk for anyone buying new today, not just a spec-sheet trade-off. Read our full Lexie hearing aids review for the details.
The case for Jabra Enhance
Jabra Enhance Select 700
- Built on the same platform as ReSound's 2025 Vivia clinic aid, with SoundScape Auto Focus for speech in noise.
- Hands-free Bluetooth calling and music streaming to both iPhone and Android.
- Remote care from licensed audiologists, a 100-day risk-free trial, and a 3-year warranty.
- Succeeds the Select 500, which earned an "A" SoundGrade from HearAdvisor — top 5% of all devices tested.
Jabra Enhance’s edge is top-rated sound plus clinical support — and, now, the safer buy overall. You still self-fit online, but licensed audiologists remotely fine-tune your devices, and you get a 100-day trial plus a 3-year warranty to take the risk out of buying without a clinic visit. For Android users who want true hands-free calling in their ears, Jabra is the stronger pick of the two. If your budget is tighter, the Jabra Enhance Select 50R (~$1,195) keeps the same care package for several hundred dollars less. See our Jabra hearing aids review for the full lineup.
Which should you buy?
- Choose Jabra Enhance if you’re buying new today. It has the highest-rated sound lineage (an “A” SoundGrade, top 5% at HearAdvisor, on the platform the current Select 700 builds from), licensed-audiologist care, Android Bluetooth calling, a 100-day trial, and a 3-year warranty — with no wind-down risk attached.
- Choose Lexie only if you already own one and are within the support window, or you fully accept that support and warranty service end September 15, 2026. For a new purchase, we can no longer recommend it given the LXE Hearing wind-down.
For the wider field, compare both against our best OTC hearing aids and best hearing aids rankings, or the best rechargeable hearing aids guide. Cross-shopping other big brands? See our Jabra vs Sony and Eargo vs Jabra comparisons.
Who should NOT buy an OTC hearing aid
OTC hearing aids from either brand are FDA-regulated for adults with perceived mild-to-moderate hearing loss. See a hearing professional first if any of these apply:
- Your hearing loss is severe, came on suddenly, or affects one ear only — start with our severe hearing loss guide and a medical check.
- You have ear pain, drainage, or known excess earwax.
- Your tinnitus is pulsing or one-sided — see our tinnitus guide and a doctor first.
- You’re buying for a child — OTC hearing aids are for adults 18 and older only.
The bottom line
Both Lexie and Jabra make capable OTC receiver-in-canal hearing aids for perceived mild-to-moderate loss, but 2026 tips the scale firmly toward Jabra Enhance: parent company LXE Hearing is winding down all U.S. operations, with Lexie’s support and warranty guaranteed only through September 15, 2026. Lexie’s hardware — ~$999 a pair (often ~$799), Bose-tuned self-fitting sound — remains genuinely good, but it’s no longer a device we can recommend buying new. Jabra Enhance pairs top-rated sound lineage (an “A” SoundGrade, top 5% at HearAdvisor) with licensed-audiologist remote care, a 100-day trial, a 3-year warranty, and — critically — a lineup that’s here to stay. Not sure a big brand is worth it? Compare against our budget picks, or browse currently-supported Jabra Enhance devices on Amazon.